Adipose MSCs Suppress MCF7 and MDA-MB-231 Breast Cancer Metastasis and EMT Pathways Leading to Dormancy via Exosomal-miRNAs Following Co-Culture Interaction

Abstract

Globally, breast cancer is the most frequently diagnosed cancer in women, and it remains a substantial clinical challenge due to cancer relapse. The presence of a subpopulation of dormant breast cancer cells that survived chemotherapy and metastasized to distant organs may contribute to relapse. Tumor microenvironment (TME) plays a significant role as a niche in inducing cancer cells into dormancy as well as involves in the reversible epithelial-to-mesenchymal transition (EMT) into aggressive phenotype responsible for cancer-related mortality in patients. Mesenchymal stem cells (MSCs) are known to migrate to TME and interact with cancer cells via secretion of exosome- containing biomolecules, microRNA. Understanding of interaction between MSCs and cancer cells via exosomal miRNAs is important in determining the therapeutic role of MSC in treating breast cancer cells and relapse. In this study, exosomes were harvested from a medium of indirect co-culture of MCF7-luminal and MDA-MB-231-basal breast cancer cells (BCCs) subtypes with adipose MSCs. The interaction resulted in different exosomal miRNAs profiles that modulate essential signaling pathways and cell cycle arrest into dormancy via inhibition of metastasis and epithelial-to-mesenchymal transition (EMT). Overall, breast cancer cells displayed a change towards a more dormant-epithelial phenotype associated with lower rates of metastasis and higher chemoresistance. The study highlights the crucial roles of adipose MSCs in inducing dormancy and identifying miRNAs-dormancy related markers that could be used to identify the metastatic pattern, predict relapses in cancer patients and to be potential candidate targets for new targeted therapy.

Autologous fat grafting for breast reconstruction after breast cancer: a 12-year experience

“…Despite early detection and guideline-based treatment of breast cancer, a proportion of patients develop tumor recurrence or metastases months to years later [ 3 ]. There are different prognostic factors that, individually or in combination, may favor tumor recurrence.…”

Exosomes: A New Pathway for Cancer Drug Resistance

“…Exosomes were discovered by Pan et al while studying the transition of reticulocytes to mature red blood cells (1), and were later defined by Johnstone et al as vesicles that containing non-essential proteins that are expelled from cells (2) following the fusion of microvesicles with the cell membranes (3). Subsequent studies showed that exosomes are released from blood cells, tumor cells, epithelial cells, mesenchymal stem cells and neuronal cells into the blood, saliva, urine and other body fluids (4-7).…”

Obesity-Related Cross-Talk between Prostate Cancer and Peripheral Fat: Potential Role of Exosomes

“…However, these drugs still have deadly side effects, and more research is needed to confirm their exact value in oncology treatment. Many cancer cells, including PCa can release both pro- and anti-cancer bipartite exosomes, and adipocytes can also release exosomes that activate inflammatory responses in the tumor microenvironment and thus inhibit cancer proliferation and spread [ 148 , 149 , 150 ]. Therefore, the extraction of potential oncogenic exosomes from adipose exosomes may promote tumor targeting therapy.…”